GS-9450 + GS-9450 Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Nonalcoholic Steatohepatitis
Conditions
Nonalcoholic Steatohepatitis
Trial Timeline
Aug 1, 2008 → Sep 1, 2009
NCT ID
NCT00740610About GS-9450 + GS-9450 Placebo
GS-9450 + GS-9450 Placebo is a phase 2 stage product being developed by Gilead Sciences for Nonalcoholic Steatohepatitis. The current trial status is completed. This product is registered under clinical trial identifier NCT00740610. Target conditions include Nonalcoholic Steatohepatitis.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00740610 | Phase 2 | Completed |
| NCT00725803 | Phase 2 | Completed |
Competing Products
20 competing products in Nonalcoholic Steatohepatitis